GHTM

Global Health and Tropical Medicine

  • GHTM
    • Vision
    • Mission
    • Governance
    • Scientific Advisory Board
  • News
    • Outreach
    • Events
      • GHTM Sessions
      • Workshops
    • Articles
    • Jobs
  • Research
    • Cross-cutting issues
      • Global Pathogen Dispersion and Population Mobility
      • Drug Discovery and Drug Resistance
      • Diagnostics
      • Public Health Information
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • THOP – TB, HIV and opportunistic diseases and pathogens
      • VBD – Vector borne diseases and pathogens
      • IHC – Individual health care
    • Research in numbers
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
    • Members
      • Population health, policies and services
        • PPS PhD members
        • PPS non PhD members
      • TB, HIV and opportunistic diseases and pathogens
        • THOP PhD members
        • THOP non PhD members
      • Vector-borne diseases and pathogens
        • VBD PhD members
        • VBD non PhD members
      • Individual Health Care
        • IHC PhD members
        • IHC non PhD members
      • Technical / administrative support
  • Publications
  • Education
    • Master Theses
    • PhD Theses
  • Services
Home / Publicações / Escape from neutralization is a frequent event in HIV-2 infection and is strongly associated with X4 tropism

Escape from neutralization is a frequent event in HIV-2 infection and is strongly associated with X4 tropism

  • Autores: Antunes F, Barroso H, Borrego P, Doroana M, Marcelino JM, Nilsson C, Novo C, Taveira N
  • Journal: AIDS Research and Human Retroviruses
  • Link: https://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=1&SID=W1nslz6EeRqf8Bzyzm3&page=1&doc=1

Title Escape from neutralization is a frequent event in HIV-2 infection and is strongly associated with X4 tropism. Background HIV-2 infection induces the production of a broad neutralizing antibody (NAb) response and this has been linked to a better control of viral replication and disease progression. However, little is known about the neutralizing targets and the dynamics of the NAb response and viral escape from neutralization during HIV-2 infection. This study was set out to investigate these issues. Methods A cohort of 28 HIV-2 infected patients followed during 4 years was analyzed. Autologous and heterologous neutralizing activities were determined with purified IgG antibodies in a TZM-bl cells-based assay against patient uncloned viruses. Coreceptor usage of the viruses was determined in GHOST cells. The sequence of the C2, V3 and C3 env regions was determined for all patients. Results Twenty-four new primary isolates were obtained from 12 patients. Most patients (8 out of 12) were infected with R5-viruses; the remaining 4 patients harbored X4-viruses. Autologous NAbs (median IC50 = 3.91 microgram/ml; range = 0.049-38 microgram/ml) were detected only in 6 patients, all infected with R5-viruses. Most (4/6) patients unable to produce autologous NAbs were infected with X4-viruses. All but one patient produced NAbs targeting heterologous R5-viruses. The heterologous Nab response differed widely in potency between patients (median IC50 = 4.14 microgram/ml; range = 0.049-49.08 microgram/ml). Remarkably, however, none of the patients produced antibodies against X4-viruses. A limited set of amino acids located in the V3 loop was associated with X4 tropism and resistance to neutralization. Conclusions Heterologous neutralization in HIV-2 patients is restricted to R5 isolates. Escape from autologous neutralization is a frequent event in HIV-2 infection and is strongly associated with X4 tropism. Viral determinants of neutralization resistance and X4 tropism seem to be located in the V3 region. These results have clear implications for the design of HIV-2 vaccine immunogens able to elicit the production of broadly reactive neutralizing antibodies.

Share this:

  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Pinterest (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to print (Opens in new window)

Events

IHMT selected for the pilot phase of the Research Data Repository Service of the FCT

  In order to promote good practices in Open Science with regard to research data and … [Read More...]

Paulo Ferrinho interviewed for the new e-magazine of European and Developing Countries Clinical Trials Partnership (EDCTP)

Paulo Ferrinho, professor and Diretor of Public Global Health Departament at the Instituto de … [Read More...]

How can we improve the environmental performance of our laboratories?

  Every day in NOVA's laboratories research is carried out with the consumption of numerous … [Read More...]

PhD student from GHTM attended the India|EMBO Lecture Course

Ronise Silva, a PhD student under the Tropical Diseases and Global Health program at the Institute … [Read More...]

Call for PhD Studentships

The Institute of Hygiene and Tropical Medicine (IHMT), Universidade Nova de Lisboa (NOVA), through … [Read More...]

IHMT | GHTM – APPLICATIONS ARE OPEN!

IHMT | GHTM - Applications are open for three research vacancies:   One position - PhD … [Read More...]

About GHTM

GHTM is a R&D Center that brings together researchers from IHMT with a track record in Tropical Medicine and International/Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal
+351 213 652 600
+351 213 632 105

  • Facebook
  • YouTube

Subscribe Newsletter

  • How to get to GHTM/IHMT
  • GHTM Sessions
  • Research Groups
  • Cross-cutting issues
© Copyright 2023 IHMT-UNL Todos os Direitos Reservados.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    Project UID/Multi/04413/2013